mdl 72527 and Melanoma

mdl 72527 has been researched along with Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agostinelli, E; Arancia, G; Condello, M; Molinari, A; Tempera, G; Viceconte, N1
Agostinelli, E; Arancia, G; Belli, F; Condello, M; Marra, M; Molinari, A; Palmigiani, P; Seiler, N; Vedova, LD1

Other Studies

2 other study(ies) available for mdl 72527 and Melanoma

ArticleYear
Cytotoxicity of spermine oxidation products to multidrug resistant melanoma M14 ADR2 cells: sensitization by the MDL 72527 lysosomotropic compound.
    International journal of oncology, 2009, Volume: 35, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Lysosomes; Melanoma; Microscopy, Confocal; Microscopy, Electron, Transmission; Oxidation-Reduction; Putrescine; Spermine

2009
Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): sensitization by heat and MDL 72527.
    Biochimica et biophysica acta, 2006, Volume: 1763, Issue:10

    Topics: Animals; Annexin A5; Cell Line, Tumor; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Hot Temperature; Humans; Melanoma; Microscopy, Electron; Molecular Structure; Monoamine Oxidase; Oxidation-Reduction; Putrescine; Reactive Oxygen Species; Spermine; Time Factors

2006